Your employer dropped the coverage, not your insurer. Anti-obesity medications are an optional benefit, and when the annual cost of covering them climbs, employers cut them. Understanding that the decision was made in a benefits meeting rather than a medical review changes where you push, and it is the reason appeals almost never work here.
This is one part of getting a GLP-1 covered. For the full picture, see GLP-1 Insurance Coverage: The Complete Guide.
Who actually made this decision
If your health plan is self-funded, your employer pays claims directly and the insurance company only administers the plan. The name on your card processes the paperwork. Your employer decides what gets covered.
That is why the letter feels like it came from your insurer while the decision has nothing to do with your clinical situation. Nobody reviewed your chart. A line item was removed from a benefit design.
Ask HR one question to confirm which situation you are in: is our plan self-funded or fully insured? The answer determines everything that follows.
Why employers drop it
The arithmetic is unusually stark with these drugs. Most covered medications are taken by a small fraction of employees for a limited period. GLP-1s are taken by a large fraction, indefinitely, at a high monthly cost, and uptake has risen faster than most benefit teams forecast.
An employer that budgeted for modest utilisation and saw it multiply has three options: absorb it, restrict it, or exclude it. Many restrict first, tightening criteria or adding step therapy, then exclude when that is not enough.
This matters for your strategy because it tells you what argument lands. An appeal saying the drug is medically necessary for you addresses a question nobody asked. An argument about total plan cost addresses the one they did.
Why appealing usually fails
An appeal asks the plan to reconsider a decision about your care. A benefit exclusion is not a decision about your care. There is no clinical judgment to overturn, so the appeal has nothing to bite on.
External review has the same problem. Independent reviewers examine medical necessity, not contract terms.
There is one exception worth checking. If the exclusion was applied to you but your plan documents do not actually contain it, or it was introduced mid-year without proper notice, that is a different argument and it is worth raising.
What actually has leverage
The decision gets remade every plan year. Benefit design is revisited annually, usually three to six months before renewal. That window is when employee input can change something, and it is the only point where pushing has real force.
Find out when your company sets benefits for next year and raise it before that meeting, not after the exclusion appears.
Collective requests move further than individual ones. A benefits manager weighing one complaint against a budget line will keep the budget line. Several employees, or a request routed through an employee resource group, reads as a retention and morale issue rather than one person’s disappointment.
What to do this year
Check whether your spouse’s plan covers it, if that option exists. Coverage differs sharply between employers and a mid-year qualifying event sometimes permits a switch.
Ask whether your plan offers any bridging benefit. Some employers who dropped pharmacy coverage kept a weight management programme, and a few cover the drug when prescribed for a different indication.
Look at what the drug costs without insurance before assuming it is out of reach. Manufacturer direct-purchase channels have changed the cash landscape, and the number people quote from memory is often out of date.
Do not stop abruptly without talking to your prescriber. There are practical questions about what happens next that are worth answering deliberately rather than by default.
Appeals will not move an exclusion, so the leverage is timing: asking HR before the annual benefit review is the only route with force. In the meantime, savings card eligibility and patient assistance programmes are worth checking.
Frequently asked questions
Can they drop coverage in the middle of a plan year?
Mid-year formulary changes do happen and are generally permitted with notice, though the rules differ by plan type. Ask for the plan document language that authorised it.
Does the exclusion apply if I take it for diabetes?
Often not. Exclusions are usually written around weight management specifically, so a drug prescribed for an approved non-weight indication may still be covered.
Is there any legal challenge to this?
Coverage of anti-obesity medication is not generally mandated for employer plans, which is why exclusions are lawful. Anything beyond that is a question for an employment or benefits attorney.
Will my prior authorization still be honoured?
Usually not once an exclusion takes effect. An existing approval does not survive the benefit being removed.
Should I switch to a marketplace plan?
Possible, but marketplace coverage of these drugs varies considerably and premiums without an employer contribution are substantial. Compare specifically on this drug before moving.
What if I am mid-titration?
Raise it with your prescriber promptly. Continuity has clinical implications and there may be options worth discussing while you still have supply.